A Beaverton family that has spent years searching for a replacement gene for their son’s rare genetic disorder says they are ...

Four years later, the Phams are searching for a cure after their son was diagnosed with a rare neurological disorder, hoping to raise funds for clinical trials.

By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA approved leucovorin, a decades-old ...

Shane DiGiovanna was born with epidermolysis bullosa, or EB, a condition he said is described as "the worst disease you’ve ...

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

Everyone’s favorite little blue pill may offer more than just a boost in the bedroom. New research suggests the erectile ...

Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal ...

A rare genetic disorder means seven-year-old Wyatt has found school impossible ...

Washington — The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much ...

BEAVERTON, Oregon — A Beaverton family that has spent years searching for a replacement gene for their son’s rare genetic disorder says they are seeing encouraging progress. Linda and Tommy Pham say ...

The FDA has approved a generic drug for a rare genetic disorder. It's called Leucovorin and can be used to treat a brain disorder that limits the delivery of folate, a form of vitamin B, in the body.